Minority Interest Sample Clauses

Minority Interest. As to any Person, an ownership or other equity investment in any other Person, which investment is not consolidated with the accounts of such Person in accordance with GAAP. Mortgages. Collectively, the mortgage(s) granted to Agent, on behalf of the Lenders, on any of the Borrowing Base Properties, as may be required hereunder. Multiemployer Plan. Any multiemployer plan within the meaning of §3(37) of ERISA maintained or contributed to by the Borrower or any ERISA Affiliate.

Minority Interest. The amount represents the minority shareholders’ interest in Yudu Minpin Shopping Mall (“Yudu”), a 76.1% owned subsidiary, the minority shareholders’ interest in Taiyuan Clothing City, also known as Xicheng Shopping Mall (“Xicheng”), a 76.1 % owned subsidiary, the minority shareholders’ interest in Jingpin Clothing City (“Jingpin”), a 76.1 % owned subsidiary, the minority shareholders’ interest in Longma Shopping Mall (“Longma”), a 76.1 % owned subsidiary, and the minority shareholders’ interest in Xindongcheng Clothing Distribution Mall (“Xindongcheng”), a 76.1 % owned subsidiary. All the minority shareholders in each of these five subsidiaries are related parties of the Company.

Minority Interest. In December 2007, the Financial Accounting Standards Board (FASB) issued new guidance which establishes accounting and reporting standards for ownership interests in subsidiaries held by parties other than the parent, the amount of consolidated net income (loss) attributable to the parent and to the noncontrolling interests, changes in a parent’s ownership interest and the valuation of retained noncontrolling equity investments when a subsidiary is deconsolidated. This guidance requires that the noncontrolling interest continue to be attributed its share of losses even if that attribution results in a deficit. Utilizing this guidance we have classified the noncontrolling interest in IGAM in stockholders’ equity on our Consolidated Balance Sheets on a retrospective basis. In addition, consolidated net loss has been adjusted to include the net loss attributed to the noncontrolling interest in IGAM, through April 29, 2011, the date we sold the stock we owned to a third party.

Minority Interest. The Company shall have acquired all of the outstanding capital stock of Summit Global Partners of Memphis, Inc. and the Parent shall have received satisfactory evidence of such action.

Minority Interest. In July 1997, ATI entered into a collaboration agreement with BioChem Pharma Inc. (BioChem), a biopharmaceutical company based in Quebec, Canada. This agreement granted BioChem an exclusive worldwide license to ATI's proprietary screens based on two families of proteins involved in apoptosis, for use in identifying leads for anti-cancer drug development. As of April 2000, BioChem had fulfilled all of its funding obligations under the agreement by purchasing a total of $11.1 million in non-voting, non-dividend-bearing convertible preferred stock of ATI. In April 2000, BioChem informed ATI of its decision not to extend the agreement beyond its scheduled July 31, 2000 termination date. Consequently, under the terms of the agreement, rights to all screens delivered to BioChem reverted to ATI effective August 1, 2000. However, certain provisions pertaining to the license of any products resulting from the collaboration will remain in force. As of August 1, 2000, no compound leads had been identified. The preferred stock issued to BioChem is convertible into ATI common stock at any time after three years from the date of first issuance, at a conversion price equal to the then current market price of the ATI common stock, but in any event at a price that will result in BioChem acquiring at least 15% of the then outstanding ATI common stock. Through March 31, 2001, 11,125 shares of ATI preferred stock had been issued to BioChem, representing a 15% minority interest (on an if-converted and fully diluted basis) in the net equity of ATI. This minority interest portion of ATI's loss reduced ImmunoGen's net loss in the three- and nine-month periods ended March 31, 2000 by $25,000 and $76,000, respectively. Based upon an independent appraisal, approximately 3% of the $11.1 million invested, or approximately $0.3 million, was allocated to the minority interest in ATI, with the remainder, or approximately $10.8 million, allocated to the Company's equity. As part of the BioChem agreement, BioChem also received warrants to purchase shares of ImmunoGen Common Stock equal to the amount invested in ATI during the three-year research term. Beginning July 31, 2000, these warrants became exercisable for a number of shares of ImmunoGen Common Stock determined by dividing $11.125 million, the amount of BioChem's investment in ATI, by the market price of ImmunoGen Common Stock on the exercise date, subject to certain limitations imposed by the Nasdaq Stock Market rules, which limit ...

Minority Interest. The following definition is added at the appropriate place in section 1.01 of the Canadian Credit Agreement based on the alphabetical ordering of the definitions in the section:

Minority Interest. As to any Person, an ownership or other equity investment in any other Person, which investment is not consolidated with the accounts of such Person in accordance with GAAP. MINIMUM TANGIBLE NET WORTH. At any time, the sum of (a) $190,000,000.00 plus (b) eighty percent (80%) of the aggregate net proceeds received by the Borrower, REA or any other Guarantor after the Closing Date in connection with any Equity Offering to any other Person. MORTGAGED PROPERTY OR MORTGAGED PROPERTIES. The Eligible Real Estate owned by the Borrower, REA or a Guarantor which is security for the Obligations pursuant to the Mortgages.

Minority Interest. (14.1) -------- Adjusted net income............................. 127.5 ======== Adjusted net income per share................... $ 2.14 ======== FAIRNESS OPINIONS Opinion of APY's Financial Advisor APY retained Salomon Brothers pursuant to a letter agreement dated January 3, 1997 (the "Engagement Letter") to act as financial advisor to the Special Committee in connection with its review of the proposed acquisition by AFC of the shares of APY Common Stock it did not already own and to render an opinion relating to the fairness, from a financial point of view, to the APY Public Stockholders of the consideration to be received by such holders in such proposed acquisition. Pursuant to the Engagement Letter, Salomon Brothers rendered an opinion to the Special Committee on February 19, 1997 to the effect that, based upon and subject to the considerations set forth in such opinion, as of such date, the consideration to be received by the APY Public Stockholders in the Merger was fair to such holders from a financial point of view. No limitations were imposed by the Special Committee or the APY Board on the investigations made or procedures followed by Salomon Brothers. THE FULL TEXT OF SALOMON BROTHERS' FAIRNESS OPINION, WHICH SETS FORTH THE ASSUMPTIONS MADE, GENERAL PROCEDURES FOLLOWED, MATTERS CONSIDERED AND LIMITS ON THE REVIEW UNDERTAKEN, IS INCLUDED AS APPENDIX C TO THIS INFORMATION STATEMENT/PROSPECTUS. THE SUMMARY OF SALOMON BROTHERS' OPINION SET FORTH BELOW IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO THE FULL TEXT OF SUCH OPINION INCLUDED AS APPENDIX C. HOLDERS OF APY COMMON STOCK ARE URGED TO READ THE OPINION IN ITS ENTIRETY. 28 In connection with rendering its opinion, Salomon Brothers reviewed and analyzed material bearing upon the financial and operating conditions and prospects of APY and AFC including, among other things, the following: (i) the Schedule 13D filed by AFC with respect to its ownership of APY Common Stock, as amended through the date of the opinion; (ii) the Merger Agreement; (iii) certain publicly available information concerning APY and AFC, including the Annual Reports on Form 10-K for each of APY and AFC for the years ended December 31, 1995 and December 31, 1994 and the Quarterly Reports on Form 10-Q for each of APY and AFC for the quarters ended March 31, June 30 and September 30, 1996; (iv) the statistical supplements containing certain financial information for the year and the quarter ended December 31, 1996 for each of APY a...

Minority Interest. Minority interest represents PepsiCo's 7% ownership in our principal operating subsidiary, Bottling Group, LLC. The growth in minority interest expense over the last three years is due to higher Bottling Group, LLC earnings over the same periods. INCOME TAX EXPENSE BEFORE RATE CHANGE Our full-year effective tax rate for 2001 was 36.5% before our income tax rate change benefit. This rate corresponds to an effective tax rate of 37.0% in 2000. The one-half point decrease is primarily due to the reduced impact of fixed non-deductible expenses on higher anticipated pre-tax income in 2001, partially offset by the decreased favorable impact of our foreign results. Our full-year effective tax rate for 2000 was 37.0%, compared to 37.4% in 1999. Our effective tax rate, excluding unusual impairment and other charges and credits, would have been 37.0% and